You are here: Industry Insights > AstraZeneca

News List

Oxford University launches Covid-19 vaccine study in children pharmaceutical-technology
February 18, 2021
The University of Oxford has launched the first study of ChAdOx1 nCoV-19 Covid-19 vaccine in children and young adults.
Mexico gets AstraZeneca doses from India expresspharma
February 18, 2021
The shipment amounts to about 42 per cent of the two million doses of the AstraZeneca and Oxford University vaccine the country plans to import from India.
Imfinzi Trial Does Not Meet Primary Endpoint americanpharmaceuticalreview
February 10, 2021
The KESTREL Phase III trial for AstraZeneca’s Imfinzi (durvalumab) did not meet the primary endpoint of improving overall survival (OS) versus the EXTREME treatment regimen (chemotherapy plus cetuximab), a standard of care ...
India says it has no concerns about efficacy of AstraZeneca vaccine expresspharma
February 10, 2021
South Africa delayed use of the vaccine after researchers found it offered minimal protection against mild-to-moderate COVID-19 disease caused by the country’s dominant coronavirus variant.
AZ’s Imfinzi fails to improve overall survival in head and neck cancer again pharmatimes
February 09, 2021
AstraZeneca’s Imfinzi has failed to improved overall survival (OS) in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) for the second time.
Matrix Collaborates with AstraZeneca on Trial for COVID-19 Long-Acting Antibody Combination americanpharmaceuticalreview
February 09, 2021
Matrix Medical Network® announced a collaboration with AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca's long-acting monoclonal antibody (LAAB) combination for the potential prevention of COVID-19.
AstraZeneca COVID-19 Vaccine Confirms 100% Protection Against Severe Disease in Phase III Trials americanpharmaceuticalreview
February 08, 2021
The primary analysis of the Phase III clinical trials from the UK, Brazil and South Africa, published as a preprint in The Lancet confirmed COVID-19 Vaccine AstraZeneca is safe and effective at preventing COVID-19, with no severe cases and no ...
AstraZeneca expects US trial results in next 4-6 weeks, research chief says expresspharma
February 08, 2021
Some experts had expected the data sooner than that, given the high infection rates in the United States during the period of testing.
UK launches trial to study alternating COVID-19 vaccines for different doses europeanpharmaceuticalreview
February 07, 2021
The UK Government has given £7 million of funding for a clinical trial which will investigate whether patients can be given different COVID-19 vaccines for each dose.
China approves AstraZeneca’s Forxiga for heart failure pharmaceutical-technology
February 07, 2021
China’s National Medical Products Administration (NMPA) has approved AstraZeneca’s Forxiga (dapagliflozin) for heart failure with reduced ejection fraction (HFrEF) in adults with and without type-2 diabetes.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page